InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
5
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Mohan Pankaj, Chairman & CEO. Insider active across 1 company, notably Sonnet BioTherapeutics Holdings, Inc.. In total, 9 filings have been published. Breakdown: 5 buys · 0 sell. Total volume traded: €119k. Activity tracked since 9 June 2021. The latest transaction was disclosed on 15 May 2023 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
7,554 sharesCommon StockSEC:0001493152-24-048951:0
34,375 sharesCommon StockSEC:0001493152-23-038573:0
Ideal exit: 23 Jul 2024 (T+270)
▲
371,600 shares@ US$0.22364.0% of flowCommon StockSEC:0001493152-23-017528:0
Ideal exit: 9 Feb 2024 (T+270)
▲
60,000 shares@ US$0.58527.5% of flowCommon StockSEC:0001493152-23-007915:0
Ideal exit: 10 Dec 2023 (T+270)
73,561 sharesCommon StockSEC:0001493152-23-005473:0
74,205 sharesCommon StockSEC:0001493152-22-036319:0
320,135 sharesCommon StockSEC:0001493152-22-009482:0
▲
4,000 shares@ US$1.54550.0% of flowCommon StockSEC:0001493152-21-013938:0
Ideal exit: 6 Mar 2022 (T+270)
▲
4,000 shares@ US$1.5454.3% of flowCommon StockSEC:0001493152-21-013938
Ideal exit: 6 Mar 2022 (T+270)
9 of 9 declarations
About Mohan Pankaj
Pankaj Mohan is the Chairman, President, and CEO of Sonnet BioTherapeutics Holdings, Inc. In this role, he oversees the company's operations and guides its growth strategy. His experience in the biopharmaceutical sector is essential for the development of the company's products.
